AMP 2021 Molecular Genetic Pathology (MGP) Online Self-Study Review Course

Log in for pricing

(No reviews yet) Write a Review
SKU:
311MGP21-001


This online course includes all the recorded presentations, course materials, case studies, and tests from the live virtual course held on May 20-23, 2021. 

CME/CMLE is available with the purchase of this course. Course expires December 2022.


This self-paced, on demand course features an intense update and review of molecular diagnostics to prepare for a certification examination, earn continuing education credits, receive updates in the field, and/or for a refresher in molecular pathology core concepts. The faculty are experts in the field of molecular pathology. Learn at your own pace and re-watch lectures as many times as you'd like. 

Visit the Program page for more information on the course. 

Duration: ~26.00 hrs


Pricing Information

AMP Members: $2,225.00
Nonmembers: $2,500.00

Institutional pricing is also available. Contact AMPEducation@amp.org for more information.

Note - Those who registered for the live virtual event on May 20-23 will have access to the recordings on the virtual meeting platform until August 1, 2021. If you wish to extend the access, purchase of the on-demand course is available for a steep discount. Email AMPEducation@amp.org for details.


Faculty


COURSE DIRECTOR:

Gregory Tsongalis, PhD, HCLD, CC
Dartmouth-Hitchcock Health System
Hunter Best, PhD, FACMG
University of Utah School of Medicine /ARUP Laboratories
Lawrence Jennings, MD, PhD, D(ABHI)
Northwestern University Feinberg School of Medicine

Honey V. Reddi, PhD, FACMG
Medical College of Wisconsin

John M. Butler, PhD
National Institute of Standards and
Technology

Joel A. Lefferts, PhD, HCLD, DABCC
Dartmouth-Hitchcock Health System
Laura J. Tafe, MD
Dartmouth-Hitchcock Health System
Erin H. Graf, PhD, D(ABMM)
Mayo Clinic Arizona
Valentina Nardi, MD
Harvard Medical School, Massachusetts General Hospital
Gail H. Vance, MD
Indiana University School of Medicine



Continuing Education Credit Information

Maximum CME credit available: 26.00
Maximum CMLE credit available: 25.50   

Last day to purchase course and claim credit: December 31, 2022 (please note that continuing education credit will also expire on December 31, 2022). 

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association of Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physicians (ACCME) Credit Designation

Amedco LLC designates this enduring activity for a maximum of 26.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Continuing Medical Laboratory Education (CMLE)

This activity has been planned and implemented in accordance with the Amedco and joint provider-ship of the ASC and the Association for Molecular Pathology (AMP). Course number 7012, up to 25.50 CEs.


DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).


Note: Members of AMP can access this course for a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.